透析中のESRDありの心不全患者にスピロノラクトンは安全



Spironolactone Use in Heart Failure Patients With End-Stage Renal Disease on Hemodialysis: Is It Safe?
Clinical Cardiology Volume 33, Issue 10, pages 604–608, October 2010

by internalmedicine | 2010-10-22 08:14 | 動脈硬化/循環器  

<< ベルギーの安楽死:連邦委員会報... 後顧:H1N1 2009 パン... >>